AHP K-Dur Settlement With FTC Applies To Brand And Generic Divisions
Executive Summary
American Home Products is prohibited from entering into patent infringement settlements under which the generic entrant agrees not to enter the market with a non-infringing product, a Federal Trade Commission consent order states
You may also be interested in...
FTC K-Dur Case Incorrectly Defines Market, Judge Says In Ruling For Schering
Merck-Medco's decision not to separately list Schering-Plough's K-Dur on its formulary is evidence that the drug is therapeutically substitutable and competes with other versions of potassium chloride, an administrative law judge said
FTC K-Dur Case Incorrectly Defines Market, Judge Says In Ruling For Schering
Merck-Medco's decision not to separately list Schering-Plough's K-Dur on its formulary is evidence that the drug is therapeutically substitutable and competes with other versions of potassium chloride, an administrative law judge said
AARP Eyeing AWP Lawsuits After Joining Generic Competition Cases
AARP's next area for pharmaceutical litigation may be joining state lawsuits regarding reporting of average wholesale prices